![Erhard Edwin Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erhard Edwin Lee
Chief Executive Officer at AMG Analysen & Anlagen AG
Profile
Erhard Edwin Lee is the founder and former Chief Executive Officer of AMG Analysen & Anlagen AG, which is founded in 2001.
He currently holds the position of Director at Lipideon Biotechnology AG and Glycemicon AG.
Erhard Edwin Lee active positions
Companies | Position | Start |
---|---|---|
AMG Analysen & Anlagen AG
![]() AMG Analysen & Anlagen AG Investment ManagersFinance AMG Analysen & Anlagen AG (AMG) is an independent investment management firm headquartered in Zurich, Switzerland. The firm was founded by Erhard Lee in 2001. AMG provides a range of wealth management services for private clients. | Chief Executive Officer | 2000-12-31 |
Lipideon Biotechnology AG
![]() Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Director/Board Member | - |
Glycemicon AG
![]() Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
AMG Analysen & Anlagen AG
![]() AMG Analysen & Anlagen AG Investment ManagersFinance AMG Analysen & Anlagen AG (AMG) is an independent investment management firm headquartered in Zurich, Switzerland. The firm was founded by Erhard Lee in 2001. AMG provides a range of wealth management services for private clients. | Finance |
Lipideon Biotechnology AG
![]() Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Commercial Services |
Glycemicon AG
![]() Glycemicon AG Miscellaneous Commercial ServicesCommercial Services Glycemicon AG develops novel nutraceuticals. The company was founded by Nadja Mrosek and Peter Harboe-Schmidt in 2013 and is headquartered in Brugg, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Erhard Edwin Lee